These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6181526)

  • 1. Pyrogenicity versus endotoxicity: which is more significant?
    Shanbrom E
    Prog Clin Biol Res; 1982; 93():105-13. PubMed ID: 6181526
    [No Abstract]   [Full Text] [Related]  

  • 2. Material-mediated pyrogens in medical devices: Applicability of the in vitro Monocyte Activation Test.
    Borton LK; Coleman KP
    ALTEX; 2018; 35(4):453-463. PubMed ID: 29901209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacology of Escherichia coli-L-asparaginase polyethylene glycol adduct.
    Park YK; Abuchowski A; Davis S; Davis F
    Anticancer Res; 1981; 1(6):373-6. PubMed ID: 7046623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a protocol to minimize hypersensitivity reactions with asparaginase administration.
    Bryant R
    J Intraven Nurs; 2001; 24(3):169-73. PubMed ID: 11530362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrogenicity of E. coli 055:b5 endotoxin by the USP rabbit test--a HIMA collaborative study.
    Dabbah R; Ferry E; Gunther DA; Hahn R; Mazur P; Neely M; Nicholas P; Pierce JS; Slade J; Watson S; Weary M; Sanford RL
    J Parenter Drug Assoc; 1980; 34(3):212-6. PubMed ID: 6995571
    [No Abstract]   [Full Text] [Related]  

  • 6. Pyrogen and endotoxin reactions during hemodialysis.
    Port FK; Bernick JJ
    Contrib Nephrol; 1983; 36():100-6. PubMed ID: 6839766
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacokinetics and drug monitoring of L-asparaginase treatment.
    Boos J
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):96-8. PubMed ID: 9088996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of B-cell epitopes in E. coli asparaginase II, an enzyme used in leukemia treatment.
    Werner A; Röhm KH; Müller HJ
    Biol Chem; 2005 Jun; 386(6):535-40. PubMed ID: 16006240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of pyrogenicity of bacterial endotoxins from a variety of Gram-negative bacteria as determined by the LAL test.
    Fleishman J; Fowlkes F
    Prog Clin Biol Res; 1982; 93():131-40. PubMed ID: 6750640
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of fever on blood copper level in adrenalectomized animals.
    Kiełczewska-Mrozikiewicz D; Szyszka A
    Acta Physiol Pol; 1980; 31(4):391-4. PubMed ID: 7004087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity of anticancer drugs used in children.
    Reich SD
    Cancer Nurs; 1980 Oct; 3(5):385-6. PubMed ID: 6902677
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer chemotherapy: those dreaded side effects and what to do about them. Part five.
    Levitt DZ
    RN; 1981 Feb; 44(2):56-9. PubMed ID: 6906871
    [No Abstract]   [Full Text] [Related]  

  • 13. Endotoxins and medical devices: the significance of dead bacteria.
    Williams D
    Med Device Technol; 2003 Mar; 14(2):8-11. PubMed ID: 12698690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens using Escherichia Coli-asparaginase or Erwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL).
    Kwok CS; Kham SK; Ariffin H; Lin HP; Quah TC; Yeoh AE
    Pediatr Blood Cancer; 2006 Sep; 47(3):299-304. PubMed ID: 16302217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of gamma-ray (cobalt 60) irradiation on pyrogenicity of bacterial pyrogen].
    Tanaka S; Nakaura S; Kuwamura T; Omori Y
    Eisei Shikenjo Hokoku; 1970; 88():125-7. PubMed ID: 4926461
    [No Abstract]   [Full Text] [Related]  

  • 16. [Results of a cooperative clinical study of Soviet L-asparaginase from E. coli].
    Kondrat'eva NA; Lorie IuI; Kruglova GV; Vorob'ev AI; Brilliant MD
    Probl Gematol Pereliv Krovi; 1980 Jul; 25(7):3-9. PubMed ID: 6995975
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of the immunosuppressive effects of asparaginases from Escherichia coli and Vibrio succinogenes.
    Durden DL; Distasio JA
    Cancer Res; 1980 Apr; 40(4):1125-9. PubMed ID: 6986981
    [No Abstract]   [Full Text] [Related]  

  • 18. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage.
    Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH
    Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asparaginase-induced acute parotitis: an uncommon and self-limiting complication.
    Chan GC; Chiang AK; Ha SY; Lau YL; Ong JB; Lee AC
    Med Pediatr Oncol; 2002 Jul; 39(1):73-4. PubMed ID: 12116090
    [No Abstract]   [Full Text] [Related]  

  • 20. Transient hyperthyroidism following L-asparaginase therapy for acute lymphoblastic leukemia.
    Fadilah SA; Faridah I; Cheong SK
    Med J Malaysia; 2000 Dec; 55(4):513-5. PubMed ID: 11221167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.